Skip to Main Content

Paper Details

Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation.
Nat Immunol
2
2023
CD8, CD8 T cells, PGLYRP1, PGLYRP1-deficient, PGLYRP1-deficient myeloid cells, Pglyrp1, T cells, autoimmune disease in the central nervous system, autoimmune encephalomyelitis, autoimmune neuroinflammation, autoimmunity, cancer, cancers, human, mice, myeloid cells, peptidoglycan recognition protein 1, tissue inflammation, tumor
Author NameAffiliation
Asaf MadiGene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School
Asaf MadiTel-Aviv University
Aviv RegevBroad Institute of MIT and Harvard
Aviv Regev
Aviv RegevBroad Institute of MIT and Harvard
Aviv Regev
  • 1 - 6

Datasets

Release 1.2